Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever.
Elhani I, Backes S, Kallinich T, Amaryan G, Belot A, Berendes R, Berger T, Dressler F, Foell D, Fühner S, Giese A, Hinze C, Hitzegrad AL, Horneff G, Jansson A, Klotsche J, Lainka E, Niehues T, Oommen P, Haas JP, Rietschel C, Theodoropoulo K, Vinit C, Weissbarth-Riedel E, Hentgen V, Wittkowski H.
Elhani I, et al. Among authors: haas jp.
RMD Open. 2024 Nov 24;10(4):e004677. doi: 10.1136/rmdopen-2024-004677.
RMD Open. 2024.
PMID: 39581688
Free article.